IBS Days 2026 Highlights Advances in Microbiome Modulation for IBS Management
The IBS Days 2026 conference in Bologna, Italy, focused on the latest research and clinical management strategies for Irritable Bowel Syndrome (IBS). The event covered various topics, including the role of the gut microbiome, dietary interventions, and non-pharmacological treatments. A significant focus was on postbiotic interventions, which have shown promise in improving IBS symptoms. The conference also addressed the overlap of IBS with other conditions like endometriosis and the potential misdiagnosis of IBS in women with ovarian cancer. The event emphasized the importance of personalized treatment approaches and the potential of microbiome-targeted therapies. 
